Tuesday December 21, 7:30 am Eastern Time
Company Press Release
SOURCE: Cell Robotics International, Inc.
Cell Robotics Awards Non-exclusive Lasette Distribution Rights To National Diabetic Assistance Corp.
Albuquerque, N.M., Dec. 21 /PRNewswire/ -- Cell Robotics International, Inc. (OTC Bulletin Board: CRII - news), announced today that it has granted a nonexclusive distribution agreement to National Diabetic Assistance Corp. (NDA) to sell the Personal Lasette in the United States. The Lasette is a laser finger perforator used by diabetics for sampling capillary blood for testing glucose levels. The Personal Lasette eliminates the effects of needle-phobia, minimizes pain and reduces soreness of the fingertips. The Lasette is the only U.S. Food and Drug Administration (FDA) cleared alternative to steel lancets or needle-sticks for drawing capillary blood for the 4 million diabetics in the U.S. who must daily do multiple injections of insulin to survive.
NDA is a Coral Springs, Florida based, rapidly growing provider of mail order supplies to diabetics across the U.S. NDA will mail Personal Lasette marketing and sales information to their current customers, to their mailing list of 500,000 diabetics and to an additional purchased list of approximately one million people with diabetes. Additionally they are working on establishing a monthly payment program for purchase of the Lasette for their customers.
NDA Chairman and COO, Steve Rotwein stated, ``We are delighted to be working with Cell Robotics to sell the Personal Lasette. We believe that with the reduced pain and no long-term soreness, this product will encourage our customers to test their glucose levels more often. This compliance testing should result in better health. We have committed to Cell Robotics to do an aggressive job of market and selling this product.'
Cell Robotics has begun filling rush Christmas orders and will continue to ramp-up the manufacturing and its own marketing and sales capability to sell the Personal Lasette directly. ``We are pleased to be working with Steve and his staff. They are a company with the motivation and creativity to be very effective in working with us in selling the Personal Lasette. They are highly effective at direct mail advertising and we have seen some of their pre-marketing material and it is first rate,' said Dr. Ronald K. Lohrding, Cell Robotics president and CEO.
In addition to the Lasette, Cell Robotics manufactures the In Vitro Fertilization (IVF) Workstation that is approved for sale in Europe and is increasing fertility rates there, and the Cell Robotics Workstation, a research instrument that incorporates the LaserTweezers© and LaserScissors© for manipulating and cutting cells and chromosomes. Additional corporate information is available on the Cell Robotics Web Site at cellrobotics.com, by e-mail at crii@cellrobotics.com, or by telephone at (505) 343-1131. The Lasette may be purchased at (800) 846-0590 or via e-mail at lasette@cellrobotics.com.
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; and the risks described from time to time in the Company's Securities and Exchange Commission filings.
SOURCE: Cell Robotics International, Inc.
-------------------------------------------------------------------------------- |
